SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies expects organic growth of 15%

22 Jul 2013 Evaluate

Venus Remedies is expecting 15% organic growth while projecting its topline products to grow to Rs 1,000 crore by FY’17 from the current Rs 460 crore in FY’13. The drug maker is expecting this kind of growth on back of higher exports and following R&D share of its revenue increasing from present 33% to 50% as the margins for company’s R&D products are much higher than generic products.

The company currently has 25 products under its research and development portfolio, of which 13 are already commercialized. The company has obtained patent for its Elores antibiotic against Superbugs from Japanese authorities. The product has so far received 46 patents from the developed world. The company has already launched this product in India and plans to launch it in Japan by end of 2015.

Besides, the company also hopes to increase its overall exports share to 50% from the present 31% in US, Canada, Japan, Europe and South Korean markets.

Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products.

Venus Remedies Share Price

1042.35 3.25 (0.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×